# To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP)

> **NCT05426785** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Biotronik SE & Co. KG** · enrollment: 398 (estimated)

## Conditions studied

- Implantable Cardioverter Defibrillator(ICD)

## Interventions

- **DEVICE:** 1:1 ratio for Treatment Group and Control Group

## Key facts

- **NCT ID:** NCT05426785
- **Lead sponsor:** Biotronik SE & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-15
- **Primary completion:** 2027-05-10
- **Final completion:** 2027-12-31
- **Target enrollment:** 398 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05426785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05426785, "To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05426785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*